A Brief Overview on Corona Virus Disease-2019 (COVID-19): Epidemiology and Severity

Authors

  • Disha Chouhan Department of Pharmaceutical Chemistry, School of Pharmaceutical Science and Research, Balaghat, Madhya Pradesh, India.
  • Rajesh Mujariya Department of Pharmaceutics, School of Pharmaceutical Science and Research, Balaghat, Madhya Pradesh, India.

DOI:

https://doi.org/10.9734/bpi/cidhr/v3/6541A

Keywords:

Corona virus, 2019-nCoV, COVID-2019, SARS-CoV-2

Abstract

This chapter describe the Epidemiology, Severity of COVID-19 and Practice Points from an Indian Perspective.

With the introduction and spread of the 2019 novel corona virus (2019-nCoV) or the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), there is a new public health disaster that threatens the entire world. In December 2019, the virus spread from bats to humans via unidentified intermediary species in Wuhan, Hubei Province, China.  The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 d. effective treatment forSARS-CoV-2 is lacking; however, two trials investigating the clinical efficacy of remdesivir are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS- CoV-2.

Published

2023-07-24

How to Cite

Disha Chouhan, & Rajesh Mujariya. (2023). A Brief Overview on Corona Virus Disease-2019 (COVID-19): Epidemiology and Severity . Current Innovations in Disease and Health Research Vol. 3, 85–92. https://doi.org/10.9734/bpi/cidhr/v3/6541A

Issue

Current Innovations in Disease and Health Research Vol. 3

Section

Chapters